Management of Retinitis Pigmentosa by Mesenchymal Stem Cells by Wharton's Jelly Derived Mesenchymal Stem Cells

Clinical trial NCT04224207 · COMPLETED

Trial details

NCT number: NCT04224207
Sponsor: Ankara Universitesi Teknokent
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Retinitis Pigmentosa Inherited Retinal Dystrophy

Start date: 2019-04-01
Primary completion: 2019-10-30
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.